These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21807562)

  • 1. The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux.
    Brandström P; Jodal U; Sillén U; Hansson S
    J Pediatr Urol; 2011 Dec; 7(6):594-600. PubMed ID: 21807562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Swedish infant high-grade reflux trial: Study presentation and vesicoureteral reflux outcome.
    Nordenström J; Holmdahl G; Brandström P; Sixt R; Stokland E; Sillén U; Sjöström S
    J Pediatr Urol; 2017 Apr; 13(2):130-138. PubMed ID: 27889221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Swedish infant high-grade reflux trial: UTI and renal damage.
    Nordenström J; Sjöström S; Sillén U; Sixt R; Brandström P
    J Pediatr Urol; 2017 Apr; 13(2):146-154. PubMed ID: 28215835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Swedish reflux trial in children: III. Urinary tract infection pattern.
    Brandström P; Esbjörner E; Herthelius M; Swerkersson S; Jodal U; Hansson S
    J Urol; 2010 Jul; 184(1):286-91. PubMed ID: 20488494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parental experiences and preferences regarding the treatment of vesicoureteral reflux.
    Nevéus T; Brandström P; Linnér T; Jodal U; Hansson S
    Scand J Urol Nephrol; 2012 Feb; 46(1):26-30. PubMed ID: 22008041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure.
    Akin Y; Gulmez H; Güntekin E; Baykara M; Yucel S
    Scand J Urol; 2014 Dec; 48(6):565-70. PubMed ID: 25028806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Swedish reflux trial in children: II. Vesicoureteral reflux outcome.
    Holmdahl G; Brandström P; Läckgren G; Sillén U; Stokland E; Jodal U; Hansson S
    J Urol; 2010 Jul; 184(1):280-5. PubMed ID: 20488469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Swedish reflux trial in children: IV. Renal damage.
    Brandström P; Nevéus T; Sixt R; Stokland E; Jodal U; Hansson S
    J Urol; 2010 Jul; 184(1):292-7. PubMed ID: 20494369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of endoscopic treatment of vesicoureteral reflux in children: comparison of different bulking agents.
    Stredele RJ; Dietz HG; Stehr M
    J Pediatr Urol; 2013 Feb; 9(1):71-6. PubMed ID: 22212178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic treatment of vesicoureteral reflux in an adult population: Can we teach our adult urology colleagues?
    Natsheh A; Shenfeld OZ; Farkas A; Chertin B
    J Pediatr Urol; 2010 Dec; 6(6):600-4. PubMed ID: 20189882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute 99mTc DMSA scan predicts dilating vesicoureteral reflux in young children with a first febrile urinary tract infection: a population-based cohort study.
    Sheu JN; Wu KH; Chen SM; Tsai JD; Chao YH; Lue KH
    Clin Nucl Med; 2013 Mar; 38(3):163-8. PubMed ID: 23354031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study.
    Stenbäck A; Olafsdottir T; Sköldenberg E; Barker G; Stenberg A; Läckgren G
    J Pediatr Urol; 2020 Jun; 16(3):328.e1-328.e9. PubMed ID: 32414615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of procalcitonin in predicting dilating vesicoureteral reflux in young children hospitalized with a first febrile urinary tract infection.
    Sun HL; Wu KH; Chen SM; Chao YH; Ku MS; Hung TW; Liao PF; Lue KH; Sheu JN
    Pediatr Infect Dis J; 2013 Sep; 32(9):e348-54. PubMed ID: 23584577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febrile urinary tract infections in children with an early negative voiding cystourethrogram after treatment of vesicoureteral reflux with dextranomer/hyaluronic acid.
    Sedberry-Ross S; Rice DC; Pohl HG; Belman AB; Majd M; Rushton HG
    J Urol; 2008 Oct; 180(4 Suppl):1605-9; discussion 1610. PubMed ID: 18710762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the risk of urinary tract infection in children with antenatally presenting dilating vesico-ureteric reflux?
    Evans K; Asimakadou M; Nwankwo O; Desai D; Cherian A; Mushtaq I; Cuckow P; Duffy P; Smeulders N
    J Pediatr Urol; 2015 Apr; 11(2):93.e1-6. PubMed ID: 25819378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term incidence of febrile UTI after DxHA treatment of VUR.
    Fotso Kamdem A; Galli G; Aubert D
    J Pediatr Urol; 2014 Feb; 10(1):56-61. PubMed ID: 23810062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.
    Keren R; Shaikh N; Pohl H; Gravens-Mueller L; Ivanova A; Zaoutis L; Patel M; deBerardinis R; Parker A; Bhatnagar S; Haralam MA; Pope M; Kearney D; Sprague B; Barrera R; Viteri B; Egigueron M; Shah N; Hoberman A
    Pediatrics; 2015 Jul; 136(1):e13-21. PubMed ID: 26055855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of vesicoureteral reflux in children with non-neurogenic lower urinary tract dysfunction treated with dextranomer/hyaluronic acid copolymer (Deflux).
    Van Batavia JP; Nees SN; Fast AM; Combs AJ; Glassberg KI
    J Pediatr Urol; 2014 Jun; 10(3):482-7. PubMed ID: 24290224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic hyaluronic acid/dextranomer gel implantation is effective as first-line treatment of vesicoureteral reflux (VUR) in children: a single centre experience.
    Häcker FM; Frech-Dörfler M; von Rotz M; Rudin C
    Eur J Pediatr Surg; 2011 Oct; 21(5):299-303. PubMed ID: 21688236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infections in patients with vesicoureteral reflux.
    Elder JS; Shah MB; Batiste LR; Eaddy M
    Curr Med Res Opin; 2007 Sep; 23 Suppl 4():S15-20. PubMed ID: 17931480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.